Dan Veljovich, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    GSK
    Topic: 
    Parp inhibitor consulting and speaker's bureau
    Date added: 
    08/24/2022
    Relationship end date: 
    08/24/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    AstraZeneca
    Topic: 
    Parp inhibitor consulting and speaker's bureau
    Date added: 
    08/24/2022
    Relationship end date: 
    08/24/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Eisai
    Topic: 
    Immunotherapy and TKI for uterine cancer
    Date added: 
    08/24/2022
    Relationship end date: 
    08/24/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Merck
    Topic: 
    Immunotherapy and TKI for uterine cancer
    Date added: 
    08/24/2022
    Relationship end date: 
    08/24/2022
Return to BTF Northwest Women’s Cancer Conference